טוען...
Analysis of the Zidovudine Resistance Mutations T215Y, M41L, and L210W in HIV-1 Reverse Transcriptase
Although anti-human immunodeficiency virus type 1 (HIV-1) therapies have become more sophisticated and more effective, drug resistance continues to be a major problem. Zidovudine (azidothymidine; AZT) was the first nucleoside reverse transcriptase (RT) inhibitor (NRTI) approved for the treatment of...
שמור ב:
הוצא לאור ב: | Antimicrob Agents Chemother |
---|---|
Main Authors: | , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
American Society for Microbiology
2015
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4649230/ https://ncbi.nlm.nih.gov/pubmed/26324274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.05069-14 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|